Our Abilify lawyers are currently accepting cases involving compulsive behavior. The FDA recently added warnings to Abilify’s labels detailing the drug’s link to uncontrollable urges for sex, gambling, shopping, and eating.
Abilify (aripiprazole) is prescribed to treat depression, bipolar disorder, and schizophrenia, among other mental disorders. It is prescribed to approximately 1.6 million Americans.
Since Abilify’s approval 14 years ago, the FDA has gathered information on the drug from patients, doctors and medical literature. By far the most common problem associated with Abilify is pathological gambling. All patients who experienced problematic side effects started the compulsive behavior after beginning Abilify, and all patients said their symptoms stopped or significantly reduced after stopping the drug.
If you’re interested in reading more detailed cases of specific Abilify side effects, check out our first blog on Abilify gambling lawsuits.